Virus Latency
-
Subject Areas on Research
- A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.
- ADAP1 promotes latent HIV-1 reactivation by selectively tuning KRAS-ERK-AP-1 T cell signaling-transcriptional axis.
- AIDS-related cytomegalovirus retinitis: lessons from the laboratory.
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.
- Combination therapy with anti-HIV-1 antibodies maintains viral suppression.
- Curing HIV: Seeking to Target and Clear Persistent Infection.
- Current issues in global tuberculosis control.
- Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.
- Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection.
- Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency.
- Establishment, Persistence, and Reactivation of Latent HIV-1 Infection in Renal Epithelial Cells.
- Evidence of Epstein-Barr virus heterogeneous gene expression in adult lung transplant recipients with posttransplant lymphoproliferative disorder.
- Expression of a murine cytomegalovirus early-late protein in "latently" infected mice.
- Gnidimacrin, a Potent Anti-HIV Diterpene, Can Eliminate Latent HIV-1 Ex Vivo by Activation of Protein Kinase C β.
- HIV-1 Proviral Transcription and Latency in the New Era.
- HIV-1 extrachromosomal 2-LTR circular DNA is long-lived in human macrophages.
- Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.
- Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion- blockade decrease rejection.
- Host Cell Redox Alterations Promote Latent HIV-1 Reactivation through Atypical Transcription Factor Cooperativity.
- Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection.
- Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III.
- Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies.
- Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo.
- Latency reversal and viral clearance to cure HIV-1.
- Mouse cytomegalovirus reactivation in severe combined immune deficient mice after implantation of latently infected salivary gland.
- Mouse strain differences in the chemokine response to acute lung infection with a murine gammaherpesvirus.
- On the role of human herpesvirus 6 in viral latency in nervous tissue and in cerebral lymphoma.
- Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1.
- Proliferation of HIV-infected renal epithelial cells following virus acquisition from infected macrophages.
- Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine.
- Regulation of human retroviral latency by the NF-kappa B/I kappa B family: inhibition of human immunodeficiency virus replication by I kappa B through a Rev-dependent mechanism.
- Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.
- SARS-CoV-2 and HIV-1 - a tale of two vaccines.
- SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques.
- Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency.
- Sleep and fatigue in mice infected with murine gammaherpesvirus 68.
- Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat.
- Synthesis and Structure-Activity Relationship Correlations of Gnidimacrin Derivatives as Potent HIV-1 Inhibitors and HIV Latency Reversing Agents.
- The role of microRNAs in Epstein-Barr virus latency and lytic reactivation.
- The viral and cellular microRNA targetome in lymphoblastoid cell lines.
- Three months of rifapentine and isoniazid for latent tuberculosis infection.
- To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis.
- Transcriptional Circuit Fragility Influences HIV Proviral Fate.
- beta-Endorphin enhances the replication of neurotropic human immunodeficiency virus in fetal perivascular microglia.
- c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
-
Keywords of People
- Luftig, Micah Alan, Professor of Molecular Genetics and Microbiology, Cell Biology